HangZhou Fanttest Biotech Co,. Ltd.
HangZhou Fanttest Biotech Co,. Ltd.

COVID-19/RSV/Influenza A&B Antigen Test Kit

Fanttest COVID-19/RSV/Influenza A&B Antigen Test Kit was included in ARTG(ARTG ID: 427686).The test kit of Fanttest company has obtained the TGA Certificate. It is an antigen rapid test with high sensitivity and specificity. Our products have different packaging specifications. Kit Contents has 1 Test/Kit 5 Tests/Kit 20 Tests/Kit 25 Tests/Kit .The product can simultaneously detect COVID-19, respiratory syncytial virus,influenza A and influenza B.

Contact Us
Specification Intended Use Operation

COVID-19/RSV/Influenza A&B Antigen Test Kit Specification

Product nameCOVID-19/RSV/Influenza A&B Antigen Test Kit
SpecimenNasal swab
FormatCassette
Pack/Box1T/5T/20T/25T
Shelf Life24 months
Storage temperature2-30℃
CertificateTGA


View More View Less

COVID-19/RSV/Influenza A&B Antigen Test Kit Intended Use

The COVID-19/RSV/Influenza A&B Antigen Test Kit is a lateral flow immunoassay for the qualitative detection of COVID-19, respiratory syncytial, influenza A and influenza B viral antigens in nasal/throat/nasopharyngeal swabs. The symptoms of respiratory viral infection due to COVID-19,respiratory syncytial and influenza can be similar. The test is intended as an aid in diagnosis of symptomatic individual meeting the case definition for COVID-19 within the first 7 days of symptom onset and meeting the case definition for respiratory syncytial and influenza A&B within the first 4 days of symptoms onset.

View More View Less

COVID-19/RSV/Influenza A&B Antigen Test Kit Operation steps and result interpretation

covid-19-rsv-influenza-a-b-antigen-test-kit-operation-steps.jpg


COVID-19 POSITIVE: Two colored lines appear on the membrane. One line appears in the control region (C) and the other line appears in the test region (T).

COVID-19 NEGATIVE: Only one colored line appears in the control region (C). No colored line appears in the test region (T).

COVID-19 INVALID: Control line fails to appear.


RSV POSITIVE: Two colored lines appear on the membrane. One line appears in the control region (C) and the other line appears in the test region (T).

RSV NEGATIVE: Only one colored line appears in the control region (C). No colored line appears in the test region (T).

RSV INVALID: Control line fails to appear.


Influenza A POSITIVE: It is positive for Influenza A antigen if two Red lines appear. One red line should be in the control line region (C), and the other one appears in the A test line region.

Influenza B POSITIVE: It is positive for Influenza B antigen if two Red lines appear. One red line should be in the control line region (C), and the other one appears in the B test line region.

Influenza A and B POSITIVE: It is positive for both the antigens of Influenza A and Influenza B if three red lines appear. One Red line should be in the control line region (C), and another two should appear in A test line region and B test line region.

NEGATIVE: One Red line appears in the control region (C). No red line appears in the influenza A and B test region (T).

INVALID: Control line fails to appear.


View More View Less
Please Contact Us
Please Contact Us

To monitor your health status anytime, anywhere and achieve self-inspection and self-testing.

06/16
2025
Fanttest Biotech's H. pylori Product Approved by Hong Kong Department of Health!
On April 30, 2025, Hangzhou Fanttest Biotech (hereinafter referred to as “Fanttest”) announced that its independently developed Helicobacter pylori (H. pylori) diagnostic product has successfully pa...
06/13
2025
COVID Is Still Around and a Risk to Susceptible People. What Are the Symptoms in 2025?
Most people who contract COVID today will only experience mild symptoms. However, some individuals remain at risk of severe illness and are more likely to be hospitalised. This includes older adults, ...
04/21
2025
Congratulation!! Fanttest's 6-in-1 and 8-in-1 Respiratory Infectious Diseases Combination Test Kits Has Obtained Authoritative Certification From Hong Kong Department of Health!
On April 14, 2025, Hangzhou Fanttest Biotech Co., Ltd. (hereinafter referred to as "Fanttest") announced that its independently developed rapid respiratory diseases combination test kits (6-...